You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 26 No. 2, February 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Levodopa Treatment of Parkinson's Syndrome

Improved Intellectual Functioning

Armand W. Loranger, PhD; John E. Lee, MD; Fletcher McDowell, MD

Arch Gen Psychiatry. 1972;26(2):163-168.


Abstract

Many individuals with Parkinson's syndrome have an intellectual impairment which is large enough to be of both practical and theoretical significance. Forty patients with moderate to severe parkinsonism were examined with the WAIS before and after 5 to 13 months treatment with 4 to 8 gm of levodopa (L-dopa) daily. Approximately half of them improved the equivalent of 10 IQ points or more. The greatest improvement occurred on the function on which they were the most impaired prior to treatment, namely, perceptual organization. Patients with lower pretreatment IQs improved more than those with higher IQs. There was little or no relationship between physical or affective improvement and intellectual improvement.



Author Affiliations

Helen Goodell; New York

From the departments of psychiatry (Dr. Lorger) and neurology (Miss Goodell, Drs. Lee and McDowell), Cornell University Medical College and the New York Hospital-Cornell Medical Center, New York.


Footnotes

Accepted for publication May 3, 1971.

Reprint requests to the New York Hospital-Cornell Medical Center, Department of Psychiatry, Westchester Division, 21 Bloomingdale Rd, White Plains, NY 10605 (Dr. Loranger).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dopa responsive dystonia with Turner's syndrome: clinical, genetic, and neuropsychological studies in a family with a new mutation in the GTP-cyclohydrolase I gene
Nitschke et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:806-808.
ABSTRACT | FULL TEXT  

Picture and Motor Sequencing in Parkinson's Disease
Beatty and Monson
J Geriatr Psychiatry Neurol 1990;3:192-197.
ABSTRACT  

Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates
Cummings
J Geriatr Psychiatry Neurol 1988;1:24-36.
ABSTRACT  

Inhibition of Dopamine Synthesis in Chronic Schizophrenia: Clinical Ineffectiveness of Metyrosine
Nasrallah et al.
Arch Gen Psychiatry 1977;34:649-655.
ABSTRACT  

Permanent Dementia in Idiopathic Parkinsonism Treated With Levodopa
Wolf and Davis
Arch Neurol 1973;29:276-278.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.